Department of Pharmacology, College of Medicine, Kangwon National University, Kangwon 200-701, Korea.
Korean J Physiol Pharmacol. 2011 Aug;15(4):211-6. doi: 10.4196/kjpp.2011.15.4.211. Epub 2011 Aug 31.
Glioblastoma multiforme is one of the most common and aggressive tumors in central nervous system. It often possesses characteristic necrotic lesions with hemorrhages, which increase the chances of exposure to thrombin. Thrombin has been known as a regulator of MMP-9 expression and cancer cell migration. However, the effects of thrombin on glioma cells have not been clearly understood. In the present study, influences of thrombin on glioma cell migration were examined using Boyden chamber migration assay and thrombin-induced changes in MMP-9 expression were measured using zymography, semi-quantitative RT-PCR, and Western blotting. Furthermore, underlying signaling pathways by which thrombin induces MMP-9 expression were examined. Thrombin-induced migration and MMP-9 expression were significantly potentiated in the presence of wortmannin, a PI3K inhibitor, whereas MAPK inhibitors suppressed thrombin-induced migration and MMP-9 expression in C6 glioma cells. The present data strongly demonstrate that MAPK and PI3K pathways evidently regulate thrombin-induced migration and MMP-9 expression of C6 glioma cells. Therefore, the control of these pathways might be a beneficial therapeutic strategy for treatment of invasive glioblastoma multiforme.
多形性胶质母细胞瘤是中枢神经系统中最常见和最具侵袭性的肿瘤之一。它常伴有特征性的坏死性病变伴出血,这增加了暴露于凝血酶的机会。凝血酶已被认为是 MMP-9 表达和癌细胞迁移的调节剂。然而,凝血酶对神经胶质瘤细胞的影响尚未被清楚地理解。在本研究中,使用 Boyden 室迁移测定法检查了凝血酶对神经胶质瘤细胞迁移的影响,并使用明胶酶谱、半定量 RT-PCR 和 Western blot 测定法测量了凝血酶诱导的 MMP-9 表达的变化。此外,还检查了凝血酶诱导 MMP-9 表达的潜在信号通路。在 PI3K 抑制剂wortmannin 的存在下,凝血酶诱导的迁移和 MMP-9 表达显著增强,而 MAPK 抑制剂抑制 C6 神经胶质瘤细胞中凝血酶诱导的迁移和 MMP-9 表达。本数据强烈表明,MAPK 和 PI3K 途径明显调节 C6 神经胶质瘤细胞中凝血酶诱导的迁移和 MMP-9 表达。因此,这些途径的控制可能是治疗侵袭性多形性胶质母细胞瘤的有益治疗策略。